Drug & supplement interaction

Terminalia Bellirica + Ranibizumab

Ranibizumab brand names: Lucentis, Susvimo.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Terminalia Bellirica and Ranibizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Terminalia Bellirica and Ranibizumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ranibizumab and Terminalia Bellirica in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Terminalia Bellirica safety at a glance

Terminalia Belliri... overall Use caution Generally used in food and traditional medicine, but human safety data are limited and quality of supplements varies.
Pregnancy Possibly Unsafe When used orally. One source warns against using Terminalia chebula and Terminalia bellirica during pregnancy; however, the reason for this warning is not descr... Read the full pregnancy detail
Breastfeeding Avoid Safety while breastfeeding is unknown, so avoidance is the safer choice.

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ranibizumab and Terminalia Bellirica? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Keep it in perspective

Terminalia Bellirica Does Interact With Other Medications

Terminalia Bellirica has 86 moderate known drug interactions in our database — Ranibizumab isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Terminalia Bellirica

Covers the 2,830 medications we’ve checked against Terminalia Bellirica. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Terminalia Bellirica and Ranibizumab May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Swelling Additional detail

    Terminalia Bellirica

    “In a small clinical study, two adults with hyperlipidemia developed a hypersensitivity rash, one with facial edema, within minutes of oral administration of Triphala (containing an aqueous extract of Terminalia chebula, Terminalia bellirica, and Indian gooseberry), together with guggul extract. It is unclear if this reaction was due to Triphala, guggul, or other factors.”

    Terminalia Bellirica · Natural Medicines adverse-effect record, reported in hypercholesterolemia.

    1 source cited
    1. 105741. Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res 2021;28(3):216-22 PubMed

    Ranibizumab

    Listed in the ADVERSE REACTIONS section of the FDA label for Ranibizumab. Read the label on DailyMed ›

Reported for Terminalia Bellirica but not commonly for Ranibizumab: an allergic reaction and a skin rash.

Effects for Ranibizumab come from the ADVERSE REACTIONS section of its FDA label; effects for Terminalia Bellirica come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 26,416 voluntary FDA FAERS reports for Ranibizumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Special populations

Terminalia Bellirica in Pregnancy & Breastfeeding

Pregnancy Possibly Unsafe

When used orally. One source warns against using Terminalia chebula and Terminalia bellirica during pregnancy; however, the reason for this warning is not described. Until more is known, avoid use.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Overlapping uses

What Ranibizumab Is Prescribed For, and What Terminalia Bellirica Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Ranibizumab is a prescription medicine with approved uses on its FDA label. Terminalia Bellirica is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Ranibizumab is prescribed for: Ranibizumab injection treats serious eye conditions that involve abnormal blood vessel growth or fluid leakage in the eye. It is used for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR). Susvimo (ranibizumab injection) is specifically approved for patients with wet AMD, DME, or DR who have already responded to at least two intravitreal (into-the-eye) injections of a VEGF inhibitor medication. Lucentis (ranibizumab injection) is used for wet AMD, DME, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization (abnormal blood vessel growth related to severe nearsightedness).

Terminalia Bellirica has been studied for:

  • Diabetes studied, not established Terminalia Bellirica has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Terminalia Bellirica for diabetes

    Although there has been interest in using oral Terminalia bellirica for diabetes, there is insufficient reliable information about the clinical effects of Terminalia bellirica for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Ranibizumab on your own; if you are taking Terminalia Bellirica for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

How much people look this up

Where Terminalia Bellirica and Ranibizumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Terminalia Bellirica
Steady interest

#1,306 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ranibizumab
Steady interest

#1,675 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Terminalia Bellirica reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Terminalia Bellirica and Ranibizumab records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Terminalia Bellirica

What is Terminalia Bellirica?

  • Digestive complaints and constipation
  • Respiratory issues like cough and sore throat
  • Antioxidant support
  • General wellness in Ayurvedic medicine
  • Cholesterol and metabolic support

Terminalia bellirica, often called 'Bibhitaki,' is a fruit long used in Ayurvedic medicine and is one of the three ingredients in the popular blend Triphala. Early laboratory and small human studies suggest possible antioxidant and metabolic effects, but high-quality evidence in people is limited. Talk with your pharmacist or doctor before using it, especially if you are pregnant, breastfeeding, or take other medicines.

Terminalia bellirica · Combretaceae · Dried ripe fruit · Powder (churna), capsules, tablets, decoctions, and as part of the herbal blend Triphala

An interaction check asks whether these two react with each other — it does not ask whether Terminalia Bellirica is a good idea for someone in your situation. Here is what our Terminalia Bellirica record says about it on its own.

Terminalia Bellirica: dosing

There is no well-established standardized dose for Terminalia bellirica. Traditional use and supplement products vary widely in the amount and form used.The best advice is to follow the directions on the product label and not exceed the recommended amount.

From our Terminalia Bellirica monograph — the full record covers uses, side effects and every documented interaction.

Read the full Terminalia Bellirica monograph & all interactions
Medication

About Ranibizumab Injection

What Is Ranibizumab Injection Used For?

Brand names: Lucentis, Susvimo

Ranibizumab injection treats serious eye conditions that involve abnormal blood vessel growth or fluid leakage in the eye. It is used for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).

Susvimo (ranibizumab injection) is specifically approved for patients with wet AMD, DME, or DR who have already responded to at least two intravitreal (into-the-eye) injections of a VEGF inhibitor medication. Lucentis (ranibizumab injection) is used for wet AMD, DME, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization (abnormal blood vessel growth related to severe nearsightedness).

Most-Reported Side Effects for Ranibizumab

From FAERS, the FDA’s public side-effect reporting system (26,591 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Visual acuity reduced 2,907 reports
Visual impairment 1,654 reports
Cerebrovascular accident 1,238 reports
Blindness 1,051 reports
Eye haemorrhage 1,047 reports
See full Ranibizumab Injection drug information
Keep checking

Other Drugs & Terminalia Bellirica

Browse every other medication we’ve checked against Terminalia Bellirica — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
86Moderate
0Minor
2,743No known interaction
Moderate

86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Terminalia Bellirica page.

No interaction 2,743 drugs checked — show the list
Evidence & sources

Terminalia Bellirica References

The 4 references that drive our Terminalia Bellirica monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.
  2. Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. PubMed
  3. Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res 2021;28(3):216-22 PubMed
  4. Das A, Naveen J, Sreerama YN, Gnanesh Kumar BS, Baskaran V. Low-glycemic foods with wheat, barley and herbs (Terminalia chebula, Terminalia bellerica and Emblica officinalis) inhibit a-amylase, a-glucosidase and DPP-IV activity in high fat and low dose st

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Terminalia Bellirica and Ranibizumab Together: Common Questions

Is it safe to take Terminalia Bellirica with Ranibizumab?
We do not list a known interaction between Terminalia Bellirica and Ranibizumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Terminalia Bellirica and Ranibizumab have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Terminalia Bellirica and Ranibizumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Terminalia Bellirica in each. That is a conversation for your prescriber, especially if Ranibizumab is being adjusted to a target.
Does Terminalia Bellirica interact with any other medications?
Yes. Terminalia Bellirica has 86 documented drug interactions in our database — Ranibizumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ranibizumab and Terminalia Bellirica?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.